These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


197 related items for PubMed ID: 22877424

  • 21. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
    Chodick G, Shalev V, Gerber Y, Heymann AD, Silber H, Simah V, Kokia E.
    Clin Ther; 2008 Nov; 30(11):2167-79. PubMed ID: 19108805
    [Abstract] [Full Text] [Related]

  • 22. Cholesterol efflux and metabolic abnormalities associated with low high-density-lipoprotein-cholesterol and high triglycerides in statin-treated coronary men with low-density lipoprotein-cholesterol <70 mg/dl.
    Posadas-Sánchez R, Posadas-Romero C, Mendoza-Pérez E, Caracas-Portilla NA, Cardoso-Saldaña G, Medina-Urrutia A, Jorge-Galarza E, Juárez-Rojas JG.
    Am J Cardiol; 2012 Mar 01; 109(5):636-41. PubMed ID: 22169129
    [Abstract] [Full Text] [Related]

  • 23. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
    Koren MJ, Davidson MH, Wilson DJ, Fayyad RS, Zuckerman A, Reed DP, ALLIANCE Investigators.
    Am J Kidney Dis; 2009 May 01; 53(5):741-50. PubMed ID: 19216014
    [Abstract] [Full Text] [Related]

  • 24. Failure to achieve recommended LDL cholesterol levels by suboptimal statin therapy relates to elevated cardiac event rates.
    Baessler A, Fischer M, Huf V, Mell S, Hengstenberg C, Mayer B, Holmer S, Riegger G, Schunkert H.
    Int J Cardiol; 2005 May 25; 101(2):293-8. PubMed ID: 15882678
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Efficacy of atorvastatin after LDL-cholesterol-based dose selection in high risk dyslipidaemic patients: results of the target dose study.
    Ducobu J, Claeys M, Commers K, Van Mieghem W, Nachtergaele H, Vandenbroucke M, Deforce J.
    Curr Med Res Opin; 2007 Aug 25; 23(8):1821-7. PubMed ID: 17609019
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The association between achieving low-density lipoprotein cholesterol (LDL-C) goal and statin treatment in an employee population.
    Burton WN, Chen CY, Schultz AB, Edington DW.
    Popul Health Manag; 2010 Feb 25; 13(1):1-8. PubMed ID: 20158317
    [Abstract] [Full Text] [Related]

  • 31. Cardiovascular morbidity associated with nonadherence to statin therapy.
    Blackburn DF, Dobson RT, Blackburn JL, Wilson TW.
    Pharmacotherapy; 2005 Aug 25; 25(8):1035-43. PubMed ID: 16207093
    [Abstract] [Full Text] [Related]

  • 32. Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.
    Bullano MF, Wertz DA, Yang GW, Kamat S, Borok GM, Gandhi S, McDonough KL, Willey VJ.
    Pharmacotherapy; 2006 Apr 25; 26(4):469-78. PubMed ID: 16553504
    [Abstract] [Full Text] [Related]

  • 33. Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study.
    Zhao SP, Peng DQ, Yu BL, Huo Y, CHILLAS investigators.
    Am Heart J; 2009 Oct 25; 158(4):509-512.e1. PubMed ID: 19781407
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes.
    Wu J, Seiber E, Lacombe VA, Nahata MC, Balkrishnan R.
    Ann Pharmacother; 2011 Mar 25; 45(3):342-9. PubMed ID: 21325098
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl.
    Spencer FA, Goldberg RJ, Gore JM, Fox KA, Avezum A, Agnelli G, Kritharides L, Anderson FA, Goodman SG, FitzGerald G, Allegrone J, Brieger D, GRACE Investigators.
    Am J Cardiol; 2007 Sep 15; 100(6):913-8. PubMed ID: 17826369
    [Abstract] [Full Text] [Related]

  • 40. Effect of statin adherence on cerebrovascular disease in primary prevention.
    Perreault S, Ellia L, Dragomir A, Côté R, Blais L, Bérard A, Lalonde L.
    Am J Med; 2009 Jul 15; 122(7):647-55. PubMed ID: 19559167
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.